Literature DB >> 6532043

Local recurrence following anterior resection for carcinoma of the rectum with a stapled anastomosis.

E L Bokey, P H Chapuis, W J Hughes, S G Koorey, D Dunn.   

Abstract

Forty-four patients underwent an anterior resection for carcinoma of the rectum using the EEA stapling device. After a two-year follow-up period, two patients had developed a local recurrence alone, and four a local recurrence in the presence of disseminated disease. These were compared to a group of 108 patients with carcinoma of the rectum who had an anterior resection with a hand-sewn anastomosis. There was no difference in the incidence of local recurrence between the two groups.

Entities:  

Mesh:

Year:  1984        PMID: 6532043

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  4 in total

Review 1.  [Using a surgical stapler on the gastrointestinal tract--pro and contra].

Authors:  A H Hölscher; J R Siewert
Journal:  Langenbecks Arch Chir       Date:  1992

2.  Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma.

Authors:  E C Poulin; C M Schlachta; R Grégoire; P Seshadri; M O Cadeddu; J Mamazza
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

3.  Short- and long-term outcomes of laparoscopic surgery with extracorporeal anastomosis for transverse colon cancer: comparison of triangulating anastomosis with functional end-to-end anastomosis.

Authors:  Shin Emoto; Yosuke Fukunaga; Ryota Nakanishi; Kazuyoshi Hirayama; Tomoyuki Nagaoka; Shimpei Matsui; Toshiki Mukai; Toshiya Nagasaki; Tomohiro Yamaguchi; Takashi Akiyoshi; Tsuyoshi Konishi; Satoshi Nagayama; Masashi Ueno
Journal:  Surg Endosc       Date:  2021-08-02       Impact factor: 4.584

4.  The prognostic value of combining the CD8 + lymphocyte density and the circulating lymphocyte ratio in circumferential resection margin biopsy in rectal cancer.

Authors:  Bo Wu; Shengchao Zhao; Yaru Sheng; Lu Ren; Guoquan Song
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.